Skip to main content
Jason Efstathiou, MD, Radiation Oncology, Boston, MA

JasonA.EfstathiouMDPhD

Radiation Oncology Boston, MA

Professor of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital

Dr. Efstathiou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Efstathiou's full profile

Already have an account?

  • Office

    Massachusetts General Hospital
    55 Fruit Street
    Boston, MA 02114
    Phone+1 617-726-5866

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2004 - 2008
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 2003 - 2004
  • Harvard Medical School
    Harvard Medical SchoolClass of 2003

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2008 - 2026
  • RI State Medical License
    RI State Medical License 2021 - 2026
  • ME State Medical License
    ME State Medical License 2020 - 2025
  • NH State Medical License
    NH State Medical License 2021 - 2025
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer  
    Jason Efstathiou, MD, JAMA
  • Impact of Interfractional Motion on Hypofractionated Pencil Beam Scanning Proton Therapy and VMAT Delivery for Prostate Cancer  
    A L Zietman, Y Wang, J A Efstathiou, F H Khan, Medical Physics
  • Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features  
    Rahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA

Authored Content

  • Are We Ready to Change Management Based on Next-Generation Imaging? YES: APCCC 2022 Presentation Jason EfstathiouAugust 2022

Press Mentions

  • American Society for Radiation Oncology, Sept. 29-Oct. 2
    American Society for Radiation Oncology, Sept. 29-Oct. 2October 9th, 2024
  • IMRT vs Proton Therapy for Early Prostate Cancer?
    IMRT vs Proton Therapy for Early Prostate Cancer?October 1st, 2024
  • Quality of Life Similar with Proton Beam Therapy vs IMRT for Prostate Cancer
    Quality of Life Similar with Proton Beam Therapy vs IMRT for Prostate CancerSeptember 30th, 2024
  • Join now to see all